ArticleAnnals of translational medicine2024

More on treatment de-escalation, biomarkers of response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer: long-term outcomes and translational research findings of the PREDIX HER2 trial.

Max S ManoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.